Literature DB >> 27172309

Photopatch Testing in Chinese Patients Over 10 Years.

Yue Hu1, Duoqin Wang, Yanyun Shen, Hui Tang.   

Abstract

BACKGROUND: Photoallergic contact dermatitis (PACD) is a hypersensitivity reaction that occurs when a previously photosensitized exogenous agent comes into contact with UV radiation. The best method for testing PACD is photopatch testing (PPT).
OBJECTIVES: The primary objective of the study was to determine the frequency of PACD to 20 different photoallergens in common usage in China during a 10-year period.
METHODS: All patients (n = 6153) who had PPTs done between 2005 and 2014 at the Department of Dermatology of Huashan Hospital, Fudan University, were included.
RESULTS: A total of 3767 PACD reactions in 3668 subjects (59.61%) were recorded. Of these allergens, chlorpromazine (CPZ) (51.82%), para-aminobenzoic acid (11.94%), thimerosal (9.81%), potassium dichromate (6.37%), sulfanilamide (5.38%), and formaldehyde (4.7%) were the top 6 allergens that elicited PACD reactions. A comparison of PACD reactions between January 2005 to December 2009 and January 2010 to December 2014 revealed a statistically significant decrease in PACD reaction for chlorpromazine, potassium dichromate, p-aminobenzoic acid, and p-phenylenediamine. Formaldehyde showed a trend toward a statistically significant increase in sensitization over the 10-year period.
CONCLUSIONS: In conclusion, positive PACD reactions were most frequent to chlorpromazine in our population. New allergens such as potassium dichromate and formaldehyde should be added to the test series.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27172309     DOI: 10.1097/DER.0000000000000170

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  1 in total

1.  Photoepicutaneous tests: a series of 37 Brazilian patients.

Authors:  Maria Antonieta Rios Scherrer; Vanessa Barreto Rocha
Journal:  An Bras Dermatol       Date:  2020-08-16       Impact factor: 1.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.